Back to Search Results
The costs of controlling hazardous substances.
Find this in:
The RoSPA occupational safety & health journal
: 2004, 34, n. 4 - April
Obtaining chronic exposure data can be very expensive and unviable commercially. Computer-based toxicological modelling techniques developed for assessing potentially useful pharmaceutical agents are a cheaper alternative for assessing exposure risks.
Related Catalogue Items
Other items related to this item are:
The RoSPA occupational safety & health journal [Continues : OS&H : Occupational safety and health : RoSPA]
COSHH update : are you WEL (Workplace exposure limits) prepared?
Under control : focuses on action that can be taken to control the risk to employees from exposure to hazardous chemicals.
Long REACH of the law : European Union chemical legislation.
What's missing in your cost-benefit analysis? SWA has the answers.
Solvent exposure in apprentice spray painters.
Cost benefit analyses of occupational health and safety in Telecom.
Copper, chromium and arsenic exposure in timber treatment works.
Cost benefit analysis of health promotion in industry.
Attitudes to workplace hazardous substances.
The worksafe model regulations for chemical safety : how much benefit?